72 related articles for article (PubMed ID: 21419570)
21. Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis.
Amano H; Ito Y; Suzuki T; Kato S; Matsui Y; Ogawa F; Murata T; Sugimoto Y; Senior R; Kitasato H; Hayashi I; Satoh Y; Narumiya S; Majima M
Cancer Sci; 2009 Dec; 100(12):2318-24. PubMed ID: 19799610
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
Jain S; Chakraborty G; Raja R; Kale S; Kundu GC
Cancer Res; 2008 Oct; 68(19):7750-9. PubMed ID: 18829529
[TBL] [Abstract][Full Text] [Related]
23. Decidualization and maintenance of a functional prostaglandin system in human endometrial cell lines following transformation with SV40 large T antigen.
Chapdelaine P; Kang J; Boucher-Kovalik S; Caron N; Tremblay JP; Fortier MA
Mol Hum Reprod; 2006 May; 12(5):309-19. PubMed ID: 16556676
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors.
Petrucci G; De Cristofaro R; Rutella S; Ranelletti FO; Pocaterra D; Lancellotti S; Habib A; Patrono C; Rocca B
J Pharmacol Exp Ther; 2011 Feb; 336(2):391-402. PubMed ID: 21059804
[TBL] [Abstract][Full Text] [Related]
25. EP4 upregulation of Ras signaling and feedback regulation of Ras in human colon tissues and cancer cells.
Wu CH; Shih YW; Chang CH; Ou TT; Huang CC; Hsu JD; Wang CJ
Arch Toxicol; 2010 Sep; 84(9):731-40. PubMed ID: 20571779
[TBL] [Abstract][Full Text] [Related]
26. Prevotella intermedia induces prostaglandin E2 via multiple signaling pathways.
Guan SM; Fu SM; He JJ; Zhang M
J Dent Res; 2011 Jan; 90(1):121-7. PubMed ID: 21057037
[TBL] [Abstract][Full Text] [Related]
27. Activation of telomerase and cyclooxygenase-2 in PDGF and FGF inhibition of C2-ceramide-induced apoptosis.
Chien CC; Shen SC; Yang LY; Wu CY; Liau JS; Chen YC
J Cell Physiol; 2009 Feb; 218(2):405-15. PubMed ID: 18932216
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
[TBL] [Abstract][Full Text] [Related]
29. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
[TBL] [Abstract][Full Text] [Related]
30. The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis.
Jain S; Chakraborty G; Kundu GC
Cancer Res; 2006 Jul; 66(13):6638-48. PubMed ID: 16818637
[TBL] [Abstract][Full Text] [Related]
31. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
[TBL] [Abstract][Full Text] [Related]
32. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E₂ regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells.
Fujino H; Toyomura K; Chen XB; Regan JW; Murayama T
Biochem Pharmacol; 2011 Feb; 81(3):379-87. PubMed ID: 21070749
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.
Takahashi T; Uehara H; Ogawa H; Umemoto H; Bando Y; Izumi K
Oncotarget; 2015 Mar; 6(7):4829-44. PubMed ID: 25638159
[TBL] [Abstract][Full Text] [Related]
36. [Epidermal growth factor stimulates the proliferation of human esophageal squamous cell carcinoma HKESC-1 cells by increasing COX-2 expression].
Yu L; Cho CH; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1323-6. PubMed ID: 21868314
[TBL] [Abstract][Full Text] [Related]
37. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone promoted gastric cancer growth through prostaglandin E receptor (EP2 and EP4) in vivo and in vitro.
Shin VY; Jin HC; Ng EK; Cho CH; Leung WK; Sung JJ; Chu KM
Cancer Sci; 2011 May; 102(5):926-33. PubMed ID: 21261791
[TBL] [Abstract][Full Text] [Related]
38. Additive effects of ulinastatin and docetaxel on growth of breast cancer xenograft in nude mice and expression of PGE2, IL-10, and IL-2 in primary breast cancer cells.
Zhong B; Shen H; Sun X; Wang H; Zhang Y; Sun Z
Cancer Biother Radiopharm; 2012 May; 27(4):252-8. PubMed ID: 22594905
[TBL] [Abstract][Full Text] [Related]
39. Definition of Prostaglandin E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth.
Ma X; Aoki T; Tsuruyama T; Narumiya S
Cancer Res; 2015 Jul; 75(14):2822-32. PubMed ID: 26018088
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
